Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s

RonanRx, a startup from Y Combinator's Summer 26 batch, offers personalized GLP-1 therapies and peptides. Traditional one-size-fits-all dosing is inadequate for individual bodies, so RonanRx tailors each patient's plan. A physician reviews the patient's medical history, sets the starting dose, and determines the titration schedule.

If needed, a patient-specific adjunct like B12 or anti-nausea support can be added to improve tolerability. A licensed pharmacist at the patient's chosen pharmacy verifies the prescription and dispenses only what the physician orders. This patient-centered approach addresses the side effects that often lead people to discontinue GLP-1 treatments.

While personalized care cannot guarantee weight loss, it significantly improves the care experience by providing a fitting dose from the beginning and ongoing support. The care model involves a doctor-led, pharmacist-reviewed chain of authority, ensuring transparency and accountability. Compounded medications, though not FDA-approved, may be more affordable than brand-name GLP-1s and can be a cost-effective alternative.

RonanRx does not set medication prices, and actual costs depend on the prescriber's plan, pharmacy, and state. Interested individuals can join the HRT waitlist or use Elite Care Pharmacy LLC for convenience.